Czech National Bank boosted its position in The Clorox Company (NYSE:CLX – Get Rating) by 0.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,442 shares of the company's stock after buying an additional 129 shares during the quarter. Czech National Bank's holdings in Clorox were worth $2,027,000 at the end of the most recent quarter.
A number of other institutional investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its holdings in Clorox by 1.3% in the 1st quarter. Vanguard Group Inc. now owns 14,685,046 shares of the company's stock worth $2,041,661,000 after buying an additional 185,012 shares in the last quarter. BlackRock Inc. raised its stake in shares of Clorox by 5.6% in the 3rd quarter. BlackRock Inc. now owns 10,964,049 shares of the company's stock valued at $1,407,673,000 after purchasing an additional 580,982 shares in the last quarter. State Street Corp raised its stake in shares of Clorox by 9.6% in the 2nd quarter. State Street Corp now owns 8,907,083 shares of the company's stock valued at $1,255,721,000 after purchasing an additional 778,269 shares in the last quarter. Wells Fargo & Company MN raised its stake in shares of Clorox by 2.4% in the 2nd quarter. Wells Fargo & Company MN now owns 3,557,161 shares of the company's stock valued at $501,489,000 after purchasing an additional 82,698 shares in the last quarter. Finally, Federated Hermes Inc. raised its stake in shares of Clorox by 11.1% in the 3rd quarter. Federated Hermes Inc. now owns 2,161,323 shares of the company's stock valued at $277,492,000 after purchasing an additional 215,425 shares in the last quarter. Institutional investors and hedge funds own 79.12% of the company's stock.
Get Clorox alerts:Clorox Price Performance
NYSE CLX opened at $157.50 on Friday. The Clorox Company has a 52 week low of $120.50 and a 52 week high of $160.59. The company has a current ratio of 0.86, a quick ratio of 0.47 and a debt-to-equity ratio of 5.04. The stock has a market cap of $19.46 billion, a price-to-earnings ratio of 45.00, a price-to-earnings-growth ratio of 3.12 and a beta of 0.29. The company has a 50-day moving average price of $150.56 and a two-hundred day moving average price of $144.96.
Clorox (NYSE:CLX – Get Rating) last posted its earnings results on Thursday, February 2nd. The company reported $0.98 EPS for the quarter, topping the consensus estimate of $0.66 by $0.32. Clorox had a net margin of 6.16% and a return on equity of 89.97%. The firm had revenue of $1.72 billion during the quarter, compared to analysts' expectations of $1.66 billion. During the same quarter in the prior year, the firm earned $0.66 EPS. Clorox's quarterly revenue was up 1.4% on a year-over-year basis. Analysts forecast that The Clorox Company will post 4.23 EPS for the current year.
Clorox Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, May 12th. Shareholders of record on Wednesday, April 26th will be given a $1.18 dividend. This represents a $4.72 annualized dividend and a yield of 3.00%. The ex-dividend date is Tuesday, April 25th. Clorox's dividend payout ratio (DPR) is 134.86%.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently issued reports on the stock. Barclays cut their target price on shares of Clorox from $110.00 to $108.00 and set an "underweight" rating on the stock in a research note on Monday, February 6th. JPMorgan Chase & Co. upped their target price on shares of Clorox from $126.00 to $135.00 and gave the company an "underweight" rating in a research note on Friday, January 13th. StockNews.com assumed coverage on shares of Clorox in a research note on Thursday, March 16th. They issued a "hold" rating on the stock. Jefferies Financial Group upped their target price on shares of Clorox from $140.00 to $145.00 and gave the company a "hold" rating in a research note on Wednesday, February 1st. Finally, Deutsche Bank Aktiengesellschaft dropped their price objective on shares of Clorox from $152.00 to $147.00 in a research note on Monday, March 20th. Seven equities research analysts have rated the stock with a sell rating, six have given a hold rating and one has issued a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $141.00.
Clorox Profile
(Get Rating)
The Clorox Co engages in the manufacture and marketing of consumer and professional products. It operates through the following business segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment consists of cleaning products, professional products and vitamins, minerals and supplements mainly marketed and sold in the United States.
Featured Articles
- Get a free copy of the StockNews.com research report on Clorox (CLX)
- MarketBeat Week in Review – 3/20 – 3/24
- Dividend King Genuine Parts Company Upgraded On Profit Guidance
- The Bottom Is In For Accenture
- 11 Best Consumer Discretionary Stocks of 2023
- 5 Best Dividend Capture Stocks
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Get Rating).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.